Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

FDA Approves Bacteriophage Trial

FDA Approves Bacteriophage Trial News & Analysis News From the Food and Drug Administration Eye-Tracking Test Approved but they fell out of favor a few decades later of its kind in North America. The recently ap- to Help Diagnose Concussion when antibiotics arrived. Now, with multi- proved trial will be the first for IPATH, which A noninvasive test that doesn’t require drug-resistant infections on the rise, bacte- was created within the UCSD medical school comparison with a baseline assessment riophages are garnering new attention. with a primary goal to conduct rigorous clini- before an injury occurred has received FDA cal trials of phage therapies. approval to help diagnose concussion in children and adults. Measuring Breast Milk Nutrients Marketed as EyeBox, the test is ap- to Support Optimal Infant Growth proved for use in pediatric patients aged 5 A recently approved diagnostic test will help health care professionals measure the nu- years or older and in adults 67 years or younger. It tracks a person’s eye move- trient content of breast milk to guide care for infants that may be at risk of growth failure. ments while he or she watches a 4-minute video clip that moves clockwise around a TheMirisHumanMilkAnalyzerusesanin- fraredspectroscopysystemtoanalyzehuman computer monitor. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

FDA Approves Bacteriophage Trial

JAMA , Volume 321 (7) – Feb 19, 2019

FDA Approves Bacteriophage Trial

Abstract

News & Analysis News From the Food and Drug Administration Eye-Tracking Test Approved but they fell out of favor a few decades later of its kind in North America. The recently ap- to Help Diagnose Concussion when antibiotics arrived. Now, with multi- proved trial will be the first for IPATH, which A noninvasive test that doesn’t require drug-resistant infections on the rise, bacte- was created within the UCSD medical school comparison with a baseline assessment riophages are...
Loading next page...
 
/lp/american-medical-association/fda-approves-bacteriophage-trial-tYjbdNIIYW
Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2019.0510
Publisher site
See Article on Publisher Site

Abstract

News & Analysis News From the Food and Drug Administration Eye-Tracking Test Approved but they fell out of favor a few decades later of its kind in North America. The recently ap- to Help Diagnose Concussion when antibiotics arrived. Now, with multi- proved trial will be the first for IPATH, which A noninvasive test that doesn’t require drug-resistant infections on the rise, bacte- was created within the UCSD medical school comparison with a baseline assessment riophages are garnering new attention. with a primary goal to conduct rigorous clini- before an injury occurred has received FDA cal trials of phage therapies. approval to help diagnose concussion in children and adults. Measuring Breast Milk Nutrients Marketed as EyeBox, the test is ap- to Support Optimal Infant Growth proved for use in pediatric patients aged 5 A recently approved diagnostic test will help health care professionals measure the nu- years or older and in adults 67 years or younger. It tracks a person’s eye move- trient content of breast milk to guide care for infants that may be at risk of growth failure. ments while he or she watches a 4-minute video clip that moves clockwise around a TheMirisHumanMilkAnalyzerusesanin- fraredspectroscopysystemtoanalyzehuman computer monitor.

Journal

JAMAAmerican Medical Association

Published: Feb 19, 2019

There are no references for this article.